Canada - English - Health Canada

pharmascience inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 1mg; 500mg - rosiglitazone (rosiglitazone maleate) 1mg; metformin hydrochloride 500mg - biguanides

Canada - English - Health Canada

pharmascience inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 2mg; 500mg - rosiglitazone (rosiglitazone maleate) 2mg; metformin hydrochloride 500mg - biguanides

Canada - English - Health Canada

pharmascience inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 4mg; 500mg - rosiglitazone (rosiglitazone maleate) 4mg; metformin hydrochloride 500mg - biguanides

Canada - English - Health Canada

pharmascience inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 2mg; 1000mg - rosiglitazone (rosiglitazone maleate) 2mg; metformin hydrochloride 1000mg - biguanides

Canada - English - Health Canada

pharmascience inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 4mg; 1000mg - rosiglitazone (rosiglitazone maleate) 4mg; metformin hydrochloride 1000mg - biguanides

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - rosiglitazone maleate (unii: kx2339dp44) (rosiglitazone - unii:05v02f2kdg), metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - rosiglitazone 2 mg - after consultation with a healthcare professional who has considered and advised the patient of the risks and benefits of rosiglitazone, avandamet® is indicated as an adjunct to diet and exercise to improve glycemic control when treatment with both rosiglitazone and metformin is appropriate in adults with type 2 diabetes mellitus who either are: - already taking rosiglitazone, or - not already taking rosiglitazone and unable to achieve glycemic control on other diabetes medications and, in consultation with their healthcare provider, have decided not to take pioglitazone (actos® ) or pioglitazone-containing products (actoplus met® , actoplus met xr® , duetact® ) for medical reasons. - due to its mechanism of action, rosiglitazone is active only in the presence of endogenous insulin. therefore, avandamet should not be used in patients with type 1 diabetes. - coadministration of avandamet with insulin is not recommended [see warnings and precautions (5.2, 5.3)] . - initiation in patients with established new

Canada - English - Health Canada

apotex inc - metformin hydrochloride; sitagliptin (sitagliptin phosphate monohydrate) - tablet - 500mg; 50mg - metformin hydrochloride 500mg; sitagliptin (sitagliptin phosphate monohydrate) 50mg

Canada - English - Health Canada

apotex inc - metformin hydrochloride; sitagliptin (sitagliptin phosphate monohydrate) - tablet - 850mg; 50mg - metformin hydrochloride 850mg; sitagliptin (sitagliptin phosphate monohydrate) 50mg

Canada - English - Health Canada

apotex inc - metformin hydrochloride; sitagliptin (sitagliptin phosphate monohydrate) - tablet - 1000mg; 50mg - metformin hydrochloride 1000mg; sitagliptin (sitagliptin phosphate monohydrate) 50mg

Malta - English - Medicines Authority

merck healthcare kgaa frankfurter strasse 250, 64293 darmstadt, germany - sitagliptin, metformin hydrochloride - film-coated tablet - metformin hydrochloride 850 mg sitagliptin 50 mg - drugs used in diabetes